Kanwal Raghav, MD, discusses the results of a Phase 2 trial of atezolizumab and bevacizumab in patients with relapsed/refractory and unresectable malignant peritoneal mesothelioma. Dr.…
(877) 363-6376
HELPLINE
The Mesothelioma Applied Research Foundation recommends Covid-19 vaccinations in mesothelioma patients receiving immunotherapy treatments. We commend the unprecedented development of safe, effective Covid-19 vaccines. It is our hope that these vaccines will end the pandemic, especially for our mesothelioma community…
You asked, we listened! As a result of your requests for more information about the legal process as it relates to mesothelioma, we bring you…
The Mesothelioma Applied Research Foundation has added a new monthly mesothelioma support group call for those who are under 55 and have lost a spouse to mesothelioma. Claudine Benmar and Gwen Dew,…
Bonnie Anderson is a 19-year mesothelioma survivor. She discusses her peritoneal mesothelioma diagnosis in 2002, her history with multiple cancers, and her family’s advocacy efforts…
Despite 2020’s pandemic challenges, these Fundraise for Meso events raised much needed mesothelioma awareness and funds to support the Mesothelioma Applied Research Foundation. The Foundation is especially appreciative of these event organizers for their continued support and…
In this video, Aaron Mansfield, MD, discusses a mesothelioma clinical trial currently available across the United States and in Canada using Keytruda (pembrolizumab) with or…
A panel of four mesothelioma patients discusses fertility challenges with fertility specialists and among themselves. Topics covered include diagnosis, patient advocacy, fertility details and options,…
Dr. Michele Carbone discusses the genetics of mesothelioma, and his research in this area, particularly as it relates to the BAP-1 gene. This interview is…
The Congressionally Directed Medical Research Programs’ (CDMPR), Peer Reviewed Cancer Research Program (PRCRP) consumer advocates Katie Jamieson and Jessica Blackford-Cleeton recently participated in the evaluation…